PMID: 6967963Sep 1, 1980Paper

Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae

The Journal of Pediatrics
P A ShurinD L Kasper

Abstract

We have developed a bactericidal antibody assay to determine the role of circulating antibody to nontypable strains of Haemophilus influenzae in children with otitis media. Antibody infecting strain was present in the acute sera of 2/20 children with otitis media caused by H. influenzae NT; 15/18 of these patients had covalescent specimens with titers greater than or equal to 1:2 (X2 = 13.0, P < 0.001). The acute sera of 95 children with otitis media caused by various organisms were screened for bactericidal activity against a randomly selected H. influenzae NT stain. Antibody was present in 0/28 acute sera of patients whose infection was caused by H. influenzae NT and in 18/67 (26.9% of those whose middleear exudates were sterile or contained other bacterial species (X2 = 9.95, P < 0.01). A bactericidal antibody response generally follows infection of the middlw ear with H. influenzae NT. The absence of antibody to a single strain in the sera of some children appears to be associated with susceptibility to this infection.

References

Feb 1, 1977·The Journal of Infectious Diseases·D L KasperW M McCormick
May 1, 1974·Pediatric Clinics of North America·C D Bluestone, P A Shurin
Jan 1, 1972·The Journal of Clinical Investigation·P AndersonD H Smith
Nov 1, 1974·The Journal of Infectious Diseases·C W Norden
Jun 1, 1969·The Journal of Experimental Medicine·I GoldschneiderM S Artenstein
Feb 19, 1970·The New England Journal of Medicine·M S ArtensteinC Harkins
Sep 29, 1966·The New England Journal of Medicine·F S Rosen, C A Janeway
Oct 6, 1966·The New England Journal of Medicine·F S Rosen, C A Janeway
Apr 1, 1950·Acta Oto-laryngologica·G BJUGGREN, G TUNEVALL
Jan 1, 1945·The Journal of Experimental Medicine·C M MacLEOD, R G HODGES

❮ Previous
Next ❯

Citations

Oct 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P H Mäkelä
Mar 1, 1997·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J M BernsteinM E Wilson
Oct 1, 1989·The Journal of Laryngology and Otology·G HarstenR Kornfält
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E CorderoE Nuño
Oct 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M Akkoyunlu, A Forsgren
Jun 9, 1998·Annals of the New York Academy of Sciences·K Prellner, O Kalm
Jun 9, 1998·Annals of the New York Academy of Sciences·G S Giebink
Oct 1, 1996·American Journal of Respiratory and Critical Care Medicine·J W Geme
Jul 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Valérie BouchetE Richard Moxon
May 5, 2007·Journal of Molecular Evolution·Ted H M Mes, Jos P M van Putten
Mar 23, 2005·Vaccine·Timothy F MurphyDavid L Klein
Aug 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·C H Sørensen, L K Nielsen
May 26, 2017·Critical Reviews in Microbiology·Krishna Bajee SriramAllan W Cripps
Sep 1, 1986·International Journal of Pediatric Otorhinolaryngology·O KalmP Christensen
Aug 1, 1991·The Annals of Otology, Rhinology, and Laryngology·P C Weber, P J Koltai
May 23, 2000·The Pediatric Infectious Disease Journal·T F Murphy
Jan 1, 1991·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·O Fujioka
Mar 20, 2015·Clinical and Vaccine Immunology : CVI·Timothy F Murphy
Jan 1, 1984·Acta Oto-laryngologica·A FreijdB Rynnel-Dagöö
Jun 3, 2009·Expert Review of Vaccines·Timothy F Murphy
May 8, 2003·Current Opinion in Infectious Diseases·Timothy F Murphy
Feb 1, 1996·Annals of Medicine·J W St Geme

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.